Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
125.00    0.00 (0.00%)
Bid:
119.00
Ask:
124.50
Spread: 5.50 (4.622%)
Market Cap: £98.09m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

12 Jan 2023 07:00

RNS Number : 4516M
Xaar PLC
12 January 2023
 

 

 

XAAR plc 

 

TRADING UPDATE

 

Xaar plc ("Xaar", "the Group" or "the Company"), the leading inkjet printing technology group, today announces a trading update for the year ended 31 December 2022.

 

TRADING

Strong revenue growth and full-year profitability

· Revenue for the period is expected to be approximately £74 million (2021: £59.3 million), representing year on year growth of 24% driven by a combination of organic growth (9%) and acquisitions

 

· The Group is expected to deliver an on track adjusted profit for the year

 

· During 2022 the Group continued to invest in working capital and infrastructure development and in March completed the acquisition of Megnajet

 

 

Further operational and strategic progress

· Further progress was made throughout the year in implementing the strategy to achieve long-term profitable growth

 

· Successful launch of Aqueous printhead product in November 2022 as planned, and on budget, is receiving strong customer engagement

 

· Factory reorganisation commenced in December and is progressing well and on schedule for completion by March 2023. This project is expected to deliver increased efficiency, reduce power usage, and reduce costs

 

· The integration of recent acquisitions (FFEI and Megnajet) has been completed successfully and both are contributing positively to Group results 

 

· Continued progress at EPS delivered its best performance to date with revenue growth of 36%

 

 

Challenging macro conditions expected to continue into 2023

· Sales volumes in the Printhead business continue to be affected by the uncertainty in China, which is expected to continue in the short term as Covid cases increase. At this stage it remains unclear when normal levels of business will return

 

· We have maintained our policy of increased investment in inventory to ensure availability of product during the factory reorganisation in Q1 2023 and the remainder of the year

 

BALANCE SHEET AND LIQUIDITY

· The Group remains well capitalised with a strong balance sheet with a net cash position as at 31 December 2022 of £8.6 million

 

 

John Mills, Chief Executive Officer, commented:

"I am hugely proud of the team in delivering a strong performance and making further progress with our strategy. We expect to deliver strong profitable revenue growth and the important milestone of achieving full year profitability representing great progress against our plan and remain well positioned for the business to achieve its exciting potential.

Aquinox has been successfully launched and is already being well received by our customers. With the operational improvements now well underway, notwithstanding the challenging external environment, the business is in good shape to continue to make further progress over the long term."

 

 

 

 

 

 

 

 

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Tulchan Communications

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFIFWFEDSEDF
Date   Source Headline
4th Jul 20143:06 pmRNSHolding(s) in Company
4th Jul 20143:01 pmRNSHolding(s) in Company
3rd Jul 20149:41 amRNSHolding(s) in Company
1st Jul 201410:38 amRNSTotal Voting Rights
1st Jul 201410:38 amRNSBlocklisting Interim Review
27th Jun 201411:31 amRNSHolding(s) in Company
25th Jun 20145:53 pmRNSHolding(s) in Company
25th Jun 20147:00 amRNSDirector/PDMR Shareholding
24th Jun 20145:05 pmRNSDirector/PDMR Shareholding
20th Jun 20144:13 pmRNSHolding(s) in Company
20th Jun 201410:36 amRNSHolding(s) in Company
20th Jun 201410:19 amRNSHolding(s) in Company
17th Jun 20147:00 amRNSTrading Update
13th Jun 20147:00 amRNSAppointment of Corporate Broker
2nd Jun 20144:00 pmRNSTotal Voting Rights
14th May 20146:10 pmRNSResult of AGM
13th May 20147:00 amRNSGrant of Options
12th May 20145:58 pmRNSDirector/PDMR Shareholding
1st May 201412:10 pmRNSTotal Voting Rights
30th Apr 201411:35 amRNSDirector/PDMR Shareholding
24th Apr 20147:00 amRNSDirector/PDMR Shareholding
23rd Apr 201410:08 amRNSNotice of 2014 AGM & Annual Financial Report
22nd Apr 20144:31 pmRNSDirector/PDMR Shareholding
17th Apr 201412:39 pmRNSDirector/PDMR Shareholding - Replacement
17th Apr 201412:08 pmRNSDirector/PDMR Shareholding
17th Apr 201411:20 amRNSDirector/PDMR Shareholding
16th Apr 20147:00 amRNSXaar plc - Interim Management Statement
10th Apr 20145:40 pmRNSHolding(s) in Company
4th Apr 201411:31 amRNSDirector/PDMR Shareholding
4th Apr 20149:13 amRNSGrant of Options
1st Apr 20149:25 amRNSTotal Voting Rights
28th Mar 20147:02 amRNSDirector/PDMR Shareholding
19th Mar 20143:58 pmRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNS2013 Full Year Results
13th Mar 20147:00 amRNSXaar plc - XAAR LAUNCHES THE XAAR 1002
28th Feb 201411:57 amRNSTotal Voting Rights
7th Feb 201410:42 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSTrading Statement
7th Jan 20147:00 amRNSBlocklisting Interim Review
2nd Jan 201411:26 amRNSTotal Voting Rights
23rd Dec 20131:47 pmRNSHolding(s) in Company
16th Dec 20133:48 pmRNSHolding(s) in Company
13th Dec 20134:34 pmRNSHolding(s) in Company
13th Dec 20139:23 amRNSHolding(s) in Company
4th Dec 20133:28 pmRNSHolding(s) in Company
4th Dec 20132:20 pmRNSHolding(s) in Company
2nd Dec 20137:00 amRNSDirector/PDMR Shareholding
31st Oct 20134:37 pmRNSTotal Voting Rights
28th Oct 20134:21 pmRNSHolding(s) in Company
17th Oct 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.